Remove about partners submit-your-opportunities
article thumbnail

MD Anderson and Xilis partner to expedite new cancer therapies development

Pharmaceutical Technology

It may offer opportunities for third-party collaborations to guide the new cell therapies and drugs development, if successful. The MOS platform can also expedite the disease model development, which offers new opportunities for further discovery research, drug development efforts, and translational science.

article thumbnail

New facility boosts UK’s cell and gene therapy manufacturing capacity

Pharmaceutical Technology

The representative expected the facility to open more treatment opportunities for UK citizens saying, “It will help give patients quick access to the latest treatments by increasing the number of UK patients with incurable diseases who are able to take part in clinical trials and bring new treatments into the NHS faster.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AstraZeneca enters $320m deal to acquire Neogene

Pharmaceutical Technology

AstraZeneca Oncology R&D executive vice-president Susan Galbraith said: “This acquisition represents a unique opportunity to bring innovative science and leading experts in T-cell receptor biology and cell therapy manufacturing together with our internal oncology cell therapy team, unlocking new ways to target cancer. Free Whitepaper.

article thumbnail

Solid Biosciences partners with Phlox for cardiac disease therapies

Pharmaceutical Technology

Solid Biosciences president and CEO Bo Cumbo said: “This collaboration with Phlox Therapeutics is an exciting opportunity to work with a company that shares our commitment and innovative approach to bringing transformative therapies to patients with rare genetic diseases. Optimise your cell therapy process: a guide to cell thawing.

RNA 130
article thumbnail

Merck and Synplogen to develop viral vector gene therapies

Pharmaceutical Technology

In nine countries globally, Merck runs M Lab Collaboration Centers, where its researchers and engineers offer partnership, technical guidance and education opportunities for customers in a completely simulated bioprocessing production lab environment. Optimise your cell therapy process: a guide to cell thawing. Free Whitepaper.

article thumbnail

Pharma wasting money on digital ads

World of DTC Marketing

3hree: Online search submitted by pharma too often relies on just one word when more searches are done with sentences. 5ive : DTC marketers are forgetting about “link building which can increase traffic by double digits if done strategically. There is a lot of huge opportunity for pharma to stop wasting money for paid search.

Marketing 148
article thumbnail

A second life for your health data? Have your say!

Sciensano

What is your opinion about the use of your health data? The use and sharing of sensitive health data represents an opportunity beyond individual care to improve public health and the quality of care and treatment received and this within a regulated and secure framework to ensure our essential right to privacy.